Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Looking to earn more? Discover simple ways to integrate money-making activities into your daily routine.
27,728 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
A bold move by Berkshire Hathaway’s new leadership shifted power in the tech landscape. This is how Greg Abel built b...
James Murdoch’s early SpaceX investment could translate into a multi-billion-dollar windfall, depending on private-ma...
A once-overlooked dividend ETF is delivering double-digit gains this year, signaling a shift from megacap leadership ...
A bipartisan housing package takes effect July 11, limiting large investors owning 350+ single-family homes from acqu...
SpaceX dazzled investors at IPO, but the price soon drifted below debut. This article shows how a $10,000 investment ...
Ethereum hit a six-week high above $1,900, extending gains after cooler inflation data. Analysts point to a mix of ma...
Facing a slide in Micron's stock, investors wonder: why is micron stock still falling? This guide breaks down the mem...
As pepsico (pep) 2026 earnings shape the near-term outlook, investors want clarity on growth drivers, costs, and capi...
Ryanair's chief financial officer says a winter shakeout could leave weaker rivals behind, boosting pricing power for...
As Berkshire transitions to Greg Abel, Warren Buffett’s final investment points to a return to era-defining brands. T...
AppLovin reported its best quarter in history, with record revenue and an 84% EBITDA margin, but the stock declined s...